PDB19 COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.207
https://www.valueinhealthjournal.com/article/S1098-3015(20)30395-8/fulltext
Section Title :
Section Order :
10067
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30395-8&doi=10.1016/j.jval.2020.04.207